Terms: = Lymphoma AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Treatment
441 results:
1. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
Kulczycka M; Derlatka K; Tasior J; Sygacz M; Lejman M; Zawitkowska J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612531
[TBL] [Abstract] [Full Text] [Related]
2. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
3. Lineage switch of kmt2a-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy.
Wu JR; Shih PC; Li C; Chao HL; Wang HC; Chiang YM; Liu YJ; Hsu SC; Yao CY; Chen LH; Lin CC; Tien HF; Chou WC
J Hematop; 2023 Jun; 16(2):103-109. PubMed ID: 38175441
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia].
Shi Y; Lu Y; Zhang RD; Zhang YY; Lin W; Yu JJ; Wu Y; Fan J; Qi PJ; Huang PL; Cai LX; Huang Q; Zhang P; Sun YM; Liu Y; Zheng HY
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):49-54. PubMed ID: 38154977
[No Abstract] [Full Text] [Related]
5. Raman classification of selected subtypes of acute lymphoblastic leukemia (ALL).
Adamczyk A; Nowakowska AM; Jakubowska J; Zabczynska M; Bartoszek M; Kashyrskaya S; Fatla A; Stawoski K; Siakala K; Pastorczak A; Ostrowska K; Mlynarski W; Majzner K; Baranska M
Analyst; 2024 Jan; 149(2):571-581. PubMed ID: 38099606
[TBL] [Abstract] [Full Text] [Related]
6. Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
Conter V; Valsecchi MG; Cario G; Zimmermann M; Attarbaschi A; Stary J; Niggli F; Dalla Pozza L; Elitzur S; Silvestri D; Locatelli F; Möricke A; Engstler G; Smisek P; Bodmer N; Barbaric D; Izraeli S; Rizzari C; Boos J; Buldini B; Zucchetti M; von Stackelberg A; Matteo C; Lehrnbecher T; Lanvers-Kaminsky C; Cazzaniga G; Gruhn B; Biondi A; Schrappe M
J Clin Oncol; 2024 Mar; 42(8):915-926. PubMed ID: 38096462
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical Analysis of Infants with Acute Lymphoblastic Leukemia (18 cases)].
Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
[TBL] [Abstract] [Full Text] [Related]
8. Acute lymphoblastic leukemia in young adults: which treatment?
Anandappa A; Curran E
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):587-592. PubMed ID: 38066918
[TBL] [Abstract] [Full Text] [Related]
9. Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia.
McNerney KO; Moskop A; Winestone LE; Baggott C; Talano JA; Schiff D; Rossoff J; Modi A; Verneris MR; Laetsch TW; Schultz L
Transplant Cell Ther; 2024 Jan; 30(1):75.e1-75.e11. PubMed ID: 37816472
[TBL] [Abstract] [Full Text] [Related]
10. Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive kmt2a fluorescence in situ hybridization result.
Nunn J; Adayapalam N; Riyat S; Seymour L; Williams B; Rehn J; White D; Moore AS; Tsuchiya K
Cancer Genet; 2023 Nov; 278-279():80-83. PubMed ID: 37742392
[TBL] [Abstract] [Full Text] [Related]
11. High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
Oikonomou A; Valsecchi L; Quadri M; Watrin T; Scharov K; Procopio S; Tu JW; Vogt M; Savino AM; Silvestri D; Valsecchi MG; Biondi A; Borkhardt A; Bhatia S; Cazzaniga G; Fazio G; Bardini M; Palmi C
Biochem Pharmacol; 2023 Nov; 217():115809. PubMed ID: 37717691
[TBL] [Abstract] [Full Text] [Related]
12. Genetic alterations and MRD refine risk assessment for kmt2a-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R; Bergugnat H; Pastoret C; Pasquier F; Raffoux E; Larcher L; Passet M; Grardel N; Delabesse E; Kubetzko S; Caye-Eude A; Meyer C; Marschalek R; Lafage-Pochitaloff M; Thiebaut-Bertrand A; Balsat M; Escoffre-Barbe M; Blum S; Baumann M; Banos A; Straetmans N; Gallego-Hernanz MP; Chalandon Y; Graux C; Soulier J; Leguay T; Hunault M; Huguet F; Lhéritier V; Dombret H; Boissel N; Clappier E
Blood; 2023 Nov; 142(21):1806-1817. PubMed ID: 37595275
[TBL] [Abstract] [Full Text] [Related]
13. BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3.
Ma L; Wang J; Yang Y; Lu J; Ling J; Chu X; Zhang Z; Tao Y; Li X; Tian Y; Li Z; Zhang Y; Sang X; Lu L; Wan X; Zhang K; Chen Y; Yu J; Zhuo R; Wu S; Pan J; Zhou X; Hu Y; Hu S
Hematology; 2023 Dec; 28(1):2247253. PubMed ID: 37594294
[TBL] [Abstract] [Full Text] [Related]
14. [Leukemia Genotype Analysis of Children with Acute Lymphoblastic Leukemia in Yunnan Area].
Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
[TBL] [Abstract] [Full Text] [Related]
15. Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children's Cancer Group study ALL-2015.
Liu K; Shao J; Cai J; Tang J; Shen S; Xu F; Ren Y; Zhang A; Tian X; Lu X; Hu S; Hu Q; Jiang H; Zhou F; Liang C; Leung AWK; Zhai X; Li C; Fang Y; Wang Z; Wen L; Yang H; Wang N; Jiang H
Ann Hematol; 2023 Dec; 102(12):3431-3444. PubMed ID: 37550503
[TBL] [Abstract] [Full Text] [Related]
16. Clonal origin of kmt2a wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy.
Coorens THH; Collord G; Treger TD; Adams S; Mitchell E; Newman B; Getz G; Godfrey AL; Bartram J; Behjati S
Nat Cancer; 2023 Aug; 4(8):1095-1101. PubMed ID: 37474833
[TBL] [Abstract] [Full Text] [Related]
17. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
[TBL] [Abstract] [Full Text] [Related]
18. A novel prognostic nomogram for adult acute lymphoblastic leukemia: a comprehensive analysis of 321 patients.
Zhang Q; Huang MJ; Wang HY; Wu Y; Chen YZ
Ann Hematol; 2023 Jul; 102(7):1825-1835. PubMed ID: 37173535
[TBL] [Abstract] [Full Text] [Related]
19. Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.
van der Sluis IM; de Lorenzo P; Kotecha RS; Attarbaschi A; Escherich G; Nysom K; Stary J; Ferster A; Brethon B; Locatelli F; Schrappe M; Scholte-van Houtem PE; Valsecchi MG; Pieters R
N Engl J Med; 2023 Apr; 388(17):1572-1581. PubMed ID: 37099340
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical Analysis of
Song Y; Gong XY; Wei SN; Li QH; Zhang GJ; Wang Y; Wei H; Lin D; Li SZ; Feng SZ; Wang JX; Mi YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):352-357. PubMed ID: 37096505
[TBL] [Abstract] [Full Text] [Related]
[Next]
